Every two years, the Center for Information and Study on Clinical Research Participation (CISCRP), an independent nonprofit organization in Boston, conducts a biennial global survey called the “Perceptions & Insights” study. The organization assesses public and patient views and experiences in clinical research.
There are some early results from the 2025 CSICRP study, which are:
- Social media can be a gateway to clinical research.
- Trust in pharma lags behind other organizations involved in clinical research.
- Helping others is the #1 reason people join clinical trials.
- 1 in 3 did not receive any compensation or reimbursement during clinical trial participation, but this varied widely by world region.
- Clinical trial participants continue to report high satisfaction levels with their participation experience.
- The majority (75 percent) would be ‘somewhat’ or ‘very comfortable’ with AI analyzing their medical data.
At OpenClinica, we believe wholeheartedly that social media is an important tool in clinical trial patient recruitment. We also will be especially curious to read about the 2025 views about decentralized clinical trials (DCTs). We know from the 2023 CISCRP study that receptivity to various types of DCTs was high.
In response to the question, How willing would you be to participate in each of the following types of clinical research studies?, respondents answered:
We believe patient preference for DCTs or remote model clinical trials is likely to be even higher in 2025 than it was in 2023.
Decentralized Clinical Trials Are One of Six Patient Recruitment Best Practices
The use of DCTs aligns with one of the six insights we included in our new clinical trial patient recruitment playbook, Executive Trends Report: Strategic Shifts Reshaping Clinical Trial Enrollment. In the playbook, we discuss insights leading research organizations that can be used by others as well as what each strategy means for sponsors, contract research organizations (CROs) and academic research facilities and the strategic implications.
To review all six insights, download our new clinical trial patient recruitment guide here.